Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Peiper

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Toxicology and Applied Pharmacology|June 7, 2019
Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylationJun He, Weitao Liu, Xin Ge, et al.
Organic & Biomolecular Chemistry|December 3, 2003
Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsHirokazu Tamamura, Kenichi Hiramatsu, Makiko Mizumoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivoJanet S Lee, Charles W Frevert, Mark M Wurfel, et al.
Angewandte Chemie (International Ed. in English)|July 24, 2003
Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based librariesNobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu, et al.
Oncotarget|October 1, 2024
Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncogene|October 10, 2020
S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancerHua Shen, Gao-Chan Wang, Xiang Li, et al.
Blood|September 3, 2010
Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonistsAditya Mandawat, Warren Fiskus, Kathleen M Buckley, et al.
Journal of the National Cancer Institute|February 22, 2007
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancyKevin T Nash, Pushkar A Phadke, Jean-Marc Navenot, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Toxicology and Applied Pharmacology|June 7, 2019
Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylationJun He, Weitao Liu, Xin Ge, et al.
Organic & Biomolecular Chemistry|December 3, 2003
Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsHirokazu Tamamura, Kenichi Hiramatsu, Makiko Mizumoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivoJanet S Lee, Charles W Frevert, Mark M Wurfel, et al.
Angewandte Chemie (International Ed. in English)|July 24, 2003
Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based librariesNobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu, et al.
Oncotarget|October 1, 2024
Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncogene|October 10, 2020
S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancerHua Shen, Gao-Chan Wang, Xiang Li, et al.
Blood|September 3, 2010
Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonistsAditya Mandawat, Warren Fiskus, Kathleen M Buckley, et al.
Journal of the National Cancer Institute|February 22, 2007
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancyKevin T Nash, Pushkar A Phadke, Jean-Marc Navenot, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Pageof 9